|
1
|
Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma.
|
Cancer
|
2005
|
1.54
|
|
2
|
Hyperammonemic encephalopathy in multiple myeloma.
|
N Engl J Med
|
2002
|
0.89
|
|
3
|
JAK2 mutations and coronary ischemia.
|
N Engl J Med
|
2010
|
0.87
|
|
4
|
Phase II study of imatinib in unresectable hepatocellular carcinoma.
|
Am J Clin Oncol
|
2008
|
0.86
|
|
5
|
Diffuse small-bowel myelomatosis.
|
N Engl J Med
|
2004
|
0.86
|
|
6
|
Sentinel-node biopsy in melanoma.
|
N Engl J Med
|
2007
|
0.80
|
|
7
|
Case 2-2012: Dyspnea and rapidly progressive respiratory failure.
|
N Engl J Med
|
2012
|
0.75
|
|
8
|
Pure red-cell aplasia secondary to antierythropoietin antibodies.
|
N Engl J Med
|
2003
|
0.75
|